140 related articles for article (PubMed ID: 23114370)
1. Corticosteroid therapy in genotype ST-11 meningococcal infections.
Madhi F; Levy C; Deghmane AE; Béchet S; Cohen R; Taha MK; ;
Pediatr Infect Dis J; 2013 Mar; 32(3):291-3. PubMed ID: 23114370
[TBL] [Abstract][Full Text] [Related]
2. [Impact of corticosteroids in the immediate management of invasive meningococcal disease associated with hyperinvasive strains of the ST-11 clonal complex in children].
Madhi F; Levy C; Deghmane AE; Béchet S; Cohen R; ; ; Taha MK
Arch Pediatr; 2014 Mar; 21(3):258-64. PubMed ID: 24485864
[TBL] [Abstract][Full Text] [Related]
3. Severity of meningococcal disease associated with genomic bacterial load.
Darton T; Guiver M; Naylor S; Jack DL; Kaczmarski EB; Borrow R; Read RC
Clin Infect Dis; 2009 Mar; 48(5):587-94. PubMed ID: 19191644
[TBL] [Abstract][Full Text] [Related]
4. Invasive meningococcal disease associated with a very high case fatality rate in the North-West of Poland.
Skoczyńska A; Kadłubowski M; Knap J; Szulc M; Janusz-Jurczyk M; Hryniewicz W
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):230-5. PubMed ID: 16487304
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Neisseria meningitidis isolates causing fatal disease.
Jacobsson S; Olcén P; Löfdahl M; Fredlund H; Mölling P
Scand J Infect Dis; 2008; 40(9):734-44. PubMed ID: 19086340
[TBL] [Abstract][Full Text] [Related]
6. Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children.
Levy C; Taha MK; Weil Olivier C; Quinet B; Lecuyer A; Alonso JM; Aujard Y; Bingen E; Cohen R;
Pediatr Infect Dis J; 2010 Jul; 29(7):618-23. PubMed ID: 20168263
[TBL] [Abstract][Full Text] [Related]
7. Variable-number tandem repeat analysis of meningococcal isolates belonging to the sequence type 162 complex.
Yazdankhah SP; Kesanopoulos K; Tzanakaki G; Kremastinou J; Caugant DA
J Clin Microbiol; 2005 Sep; 43(9):4865-7. PubMed ID: 16145161
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing.
Baethgen LF; Weidlich L; Moraes C; Klein C; Nunes LS; Cafrune PI; Lemos AP; Rios SS; Abreu MF; Kmetzsch C; Sperb AF; Riley LW; Rossetti ML; Zaha A
Trop Med Int Health; 2008 Jan; 13(1):31-40. PubMed ID: 18290999
[TBL] [Abstract][Full Text] [Related]
9. National case-control study on risk of death and Neisseria meningitidis sequence types in Denmark, 2000-2007.
Howitz M; Lambertsen L; Mølbak K; Christensen JJ
APMIS; 2008 Dec; 116(12):1107-15. PubMed ID: 19133014
[TBL] [Abstract][Full Text] [Related]
10. Impact of corticosteroids on experimental meningococcal sepsis in mice.
Levy M; Antunes A; Fiette L; Deghmane AE; Taha MK
Steroids; 2015 Sep; 101():96-102. PubMed ID: 26066898
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of Neisseria meningitidis B:NT:P1.14/162 clonal complex responsible of invasive meningococcal disease in the north of Italy.
Neri A; Fazio C; Carannante A; Mastrantonio P; Stefanelli P
Diagn Microbiol Infect Dis; 2012 Apr; 72(4):370-2. PubMed ID: 22313628
[TBL] [Abstract][Full Text] [Related]
12. Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998.
Squires SG; Pelletier L; Mungai M; Tsang R; Collins F; Stoltz J
Can Commun Dis Rep; 2000 Nov; 26(21):177-82. PubMed ID: 11107657
[No Abstract] [Full Text] [Related]
13. Myocarditis in 200 fatal meningococcal infections.
Hardman JM; Earle KM
Arch Pathol; 1969 Mar; 87(3):318-25. PubMed ID: 4974826
[No Abstract] [Full Text] [Related]
14. Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.
Wang X; Cohn A; Comanducci M; Andrew L; Zhao X; MacNeil JR; Schmink S; Muzzi A; Bambini S; Rappuoli R; Pizza M; Murphy E; Hoiseth SK; Jansen KU; Anderson AS; Harrison LH; Clark TA; Messonnier NE; Mayer LW
Vaccine; 2011 Jun; 29(29-30):4739-44. PubMed ID: 21571026
[TBL] [Abstract][Full Text] [Related]
15. Invasive pediatric Neisseria meningitidis infections.
Tuan PL; Li WC; Huang YC; Chiu CH; Lin TY
J Microbiol Immunol Infect; 2009 Oct; 42(5):427-32. PubMed ID: 20182673
[TBL] [Abstract][Full Text] [Related]
16. Meningococcal disease deaths and the frequency of antibiotic administration delays.
Lala HM; Mills GD; Barratt K; Bonning J; Manikkam NE; Martin D
J Infect; 2007 Jun; 54(6):551-7. PubMed ID: 17147958
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibility of invasive Neisseria meningitidis isolates from 1995 to 2008 in Sweden--the meningococcal population remains susceptible.
Hedberg ST; Olcén P; Fredlund H; Unemo M
Scand J Infect Dis; 2010; 42(1):61-4. PubMed ID: 19883157
[TBL] [Abstract][Full Text] [Related]
18. Meningococcal disease in New South Wales, 1991-2002.
Hogan D; McAnulty J
N S W Public Health Bull; 2004 Mar; 15(3):39-43. PubMed ID: 15124009
[No Abstract] [Full Text] [Related]
19. Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus.
Hoang LM; Thomas E; Tyler S; Pollard AJ; Stephens G; Gustafson L; McNabb A; Pocock I; Tsang R; Tan R
Clin Infect Dis; 2005 Mar; 40(5):e38-42. PubMed ID: 15714405
[TBL] [Abstract][Full Text] [Related]
20. Neisseria meningitidis sequence type and risk for death, Iceland.
Gottfredsson M; Diggle MA; Lawrie DI; Erlensdóttir H; Hardardóttir H; Kristinsson KG; Clarke Sc
Emerg Infect Dis; 2006 Jul; 12(7):1066-73. PubMed ID: 16836822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
